Azitra, Inc. Achieves NYSE American Compliance and Focuses on Growth in Innovative Dermatology
Azitra, Inc. Re-establishes Compliance with NYSE American
Azitra, Inc., a clinical-stage biopharmaceutical company specializing in innovative treatments for precision dermatology, has announced a significant achievement. As of August 19, 2026, the company has been notified by NYSE American that it has successfully regained compliance with all continued listing standards. After addressing previously noted deficiencies, Azitra will no longer carry the
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.